Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) EPS (Weighted Average and Diluted) (2017 - 2025)

Selectis Health's EPS (Weighted Average and Diluted) history spans 14 years, with the latest figure at -$0.26 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.26 for Q4 2025, down 30.0% from a year ago — trailing twelve months through Dec 2025 was -$0.34 (up 57.5% YoY), and the annual figure for FY2025 was -$0.34, up 57.5%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.26 at Selectis Health, down from $0.24 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.32 in Q1 2023 to a low of -$1.2 in Q4 2023.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.24 (2025), against an average of -$0.2.
  • The sharpest move saw EPS (Weighted Average and Diluted) soared 4507.64% in 2021, then crashed 1550.0% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.64 in 2021, then fell by 12.5% to -$0.72 in 2022, then tumbled by 66.67% to -$1.2 in 2023, then skyrocketed by 83.33% to -$0.2 in 2024, then decreased by 30.0% to -$0.26 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.26, $0.24, and -$0.1 for Q4 2025, Q3 2025, and Q2 2025 respectively.